These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6513200)

  • 1. Increase of sensitivity and uptake of vinblastine by reserpine in rat ascites hepatoma.
    Wakusawa S; Miyamoto K; Koshiura R
    Jpn J Pharmacol; 1984 Oct; 36(2):187-95. PubMed ID: 6513200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
    Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of natural resistance to vincristine in rat ascites hepatoma AH66.
    Inaba M; Takayama K; Sakurai Y
    Gan; 1981 Aug; 72(4):562-8. PubMed ID: 7308668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiform combination effects of smooth muscle relaxants with antitumor agents in rat ascites hepatoma AH66 cells.
    Takagi K; Satake T; Hasegawa T; Miyamoto K; Wakusawa S; Matsunaga T; Koshiura R
    Jpn J Pharmacol; 1987 Sep; 45(1):69-77. PubMed ID: 2824896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
    Wakusawa S; Nakamura S; Inoko K; Miyamoto K
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione-S-transferase P-form dependent chlorambucil resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M
    Cancer Lett; 1994 Apr; 78(1-3):77-83. PubMed ID: 7910111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
    Wakusawa S; Takeda K; Miyamoto K; Hidaka H
    Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity to vinblastine and mechanisms of intracellular accumulation of vinblastine by reserpine in rat ascites hepatoma cells].
    Wakusawa S; Miyamoto K; Yanaoka T; Koshiura R
    Yakugaku Zasshi; 1984 Dec; 104(12):1288-94. PubMed ID: 6533290
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination antitumor effect with central nervous system depressants on rat ascites hepatomas.
    Koshiura R; Miyamoto K; Sanae F
    Gan; 1980 Feb; 71(1):45-51. PubMed ID: 7380136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K; Inoko K; Wakusawa S; Kajita S; Hasegawa T; Takagi K; Koyama M
    Cancer Res; 1993 Apr; 53(7):1555-9. PubMed ID: 8095855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
    Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo cisplatin resistance of rat ascites hepatoma AH66.
    Minamino T; Nomura M; Tamai M; Moritani S; Ohshima T; Miyamoto K
    Cancer Lett; 1996 Nov; 108(2):153-6. PubMed ID: 8973588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells.
    Itoh Y; Tamai M; Yokogawa K; Nomura M; Moritani S; Suzuki H; Sugiyama Y; Miyamoto K
    Anticancer Res; 2002; 22(3):1649-53. PubMed ID: 12168849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the mechanisms of vinblastine membrane transport in rat ascites hepatoma AH66 cells].
    Wakusawa S; Yanaoka T; Miyamoto K; Koshiura R
    Yakugaku Zasshi; 1984 Dec; 104(12):1301-5. PubMed ID: 6533292
    [No Abstract]   [Full Text] [Related]  

  • 15. Reverse relationship between malignancy and cyclic AMP-dependent protein kinase activity in Yoshida rat ascites hepatomas.
    Miyamoto K; Nakamura S; Nomura M; Yamamoto H; Sanae F; Hidaka H
    Cancer Lett; 1993 Aug; 72(3):179-82. PubMed ID: 8402589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells.
    Tamai M; Ito Y; Mirura H; Tsukada H; Yokogawa K; Nomura M; Moritani S; Miyamoto K
    Anticancer Res; 2003; 23(6C):4781-7. PubMed ID: 14981926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on responsiveness of hepatoma cells to catecholamines. I. Lack of beta-adrenergic responsiveness in rat ascites hepatoma AH13 cells.
    Matsunaga T; Takemoto N; Miyamoto K; Koshiura R
    Jpn J Pharmacol; 1984 Dec; 36(4):499-506. PubMed ID: 6098761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma.
    Miyamoto K; Matsunaga T; Waki Y; Koshiura R
    J Pharmacobiodyn; 1986 May; 9(5):453-9. PubMed ID: 3020222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 5-fluorouracil in sensitive and resistant tumor cells.
    Fukushima M; Ikenaka K; Shirasaka T; Fujii S
    Gan; 1979 Feb; 70(1):47-53. PubMed ID: 556350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.